<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.fiercepharma.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>FDA recalls</title>
 <link>http://www.fiercepharma.com/tags/fda-recalls</link>
 <description></description>
 <language>en</language>
<item>
 <title>Top 10 Drug Warnings and Recalls of 2007</title>
 <link>http://www.fiercepharma.com/special-reports/top-10-drug-warnings-and-recalls-2007?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description>&lt;p&gt;
2007 has been a year of high-profile drug safety warnings. Check out this report for a look at the 10 biggest drugs with new, FDA-issued warnings or withdrawals this year. The drugs are ranked by 2006 worldwide sales. 
&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;
1. &lt;a href=&quot;http://www.fiercepharma.com/special-reports/antidepressants-top-10-warnings-and-recalls-2007&quot;&gt;&lt;strong&gt;Antidepressants&lt;/strong&gt; - Various companies&lt;/a&gt; 
&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;
2. &lt;a href=&quot;http://www.fiercepharma.com/special-reports/2-epogen-aranesp-top-10-warnings-and-recalls&quot;&gt;&lt;strong&gt;Epogen/Aranesp&lt;/strong&gt; - Amgen&lt;/a&gt; 
&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;
3. &lt;a href=&quot;http://www.fiercepharma.com/special-reports/3-zyprexa-top-10-warnings-and-recalls&quot;&gt;&lt;strong&gt;Zyprexa&lt;/strong&gt; - Eli Lilly&lt;/a&gt; 
&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;
4. &lt;a href=&quot;http://www.fiercepharma.com/special-reports/4-avandia-top-10-warnings-and-recalls&quot;&gt;&lt;strong&gt;Avandia&lt;/strong&gt; - GSK&lt;/a&gt; 
&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;
5. &lt;a href=&quot;http://www.fiercepharma.com/special-reports/5-actos-top-10-warnings-and-recalls&quot;&gt;&lt;strong&gt;Actos&lt;/strong&gt; - Takeda&lt;/a&gt; 
&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;
6. &lt;a href=&quot;http://www.fiercepharma.com/special-reports/6-provigil-top-10-warnings-and-recalls&quot;&gt;&lt;strong&gt;Provigil&lt;/strong&gt; - Cephalon&lt;/a&gt; 
&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;
7. &lt;a href=&quot;http://www.fiercepharma.com/special-reports/7-zelnorm-top-10-warnings-and-recalls&quot;&gt;&lt;strong&gt;Zelnorm&lt;/strong&gt; - Novartis&lt;/a&gt; 
&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;
8. &lt;a href=&quot;http://www.fiercepharma.com/special-reports/8-byetta-top-10-drug-warnings-and-recalls&quot;&gt;&lt;strong&gt;Byetta&lt;/strong&gt; - Amylin&lt;/a&gt; 
&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;
9. &lt;a href=&quot;http://www.fiercepharma.com/special-reports/9-xolair-top-10-warnings-and-recalls&quot;&gt;&lt;strong&gt;Xolair&lt;/strong&gt; - Genentech&lt;/a&gt; 
&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;
10. &lt;a href=&quot;http://www.fiercepharma.com/special-reports/10-fentora-top-10-warnings-and-recalls&quot;&gt;&lt;strong&gt;Fentora&lt;/strong&gt; - Cephalon&lt;/a&gt; 
&lt;/p&gt;
</description>
 <comments>http://www.fiercepharma.com/special-reports/top-10-drug-warnings-and-recalls-2007#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/drug-safety">drug safety</category>
 <category domain="http://www.fiercepharma.com/tags/fda-recalls">FDA recalls</category>
 <category domain="http://www.fiercepharma.com/tags/fda-warning">FDA warning</category>
 <pubDate>Thu, 29 Nov 2007 08:48:34 -0500</pubDate>
 <dc:creator>Tracy Staton</dc:creator>
 <guid isPermaLink="false">8171 at http://www.fiercepharma.com</guid>
</item>
<item>
 <title>Panel: Give FDA power to recall</title>
 <link>http://www.fiercepharma.com/story/panel-give-fda-power-recall/2007-11-06?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description>&lt;p&gt;
More power to the FDA. A presidential panel is set to recommend giving the agency the authority to recall products all by its lonesome. It would be a sea change; now, the FDA can only pressure companies to voluntarily withdraw their wares. The advisory committee--convened in response to the spate of toy, pet food, and toothpaste recalls--would also give the FDA power to cut off imports from companies that won&#039;t pony up all of their production info.
&lt;/p&gt;
&lt;p&gt;
The recommendations are just that unless and until Congress takes action. And some say they don&#039;t go far enough; for instance, they don&#039;t call for &amp;quot;trace back,&amp;quot; or a system to follow the production chain to &lt;a href=&quot;http://www.fiercepharma.com/story/fda-can-t-guarantee-drug-safety/2007-11-02?utm_medium=nl&amp;amp;utm_source=link&quot;&gt;find where contaminations occurred&lt;/a&gt;. Others said they&#039;d be worthless unless adequately funded, and as we know from &lt;a href=&quot;http://www.fiercepharma.com/story/overseas-drugmaking-goes-unsupervised/2007-10-31?utm_medium=nl&amp;amp;utm_source=link&quot;&gt;recent reports of overseas inspections&lt;/a&gt;, there&#039;s not much precedent for backing up power with pennies.
&lt;/p&gt;
&lt;p&gt;
- read the &lt;a href=&quot;http://www.cnn.com/2007/POLITICS/11/05/import.safety.ap/index.html&quot;&gt;report&lt;/a&gt; from &lt;em&gt;CNN&lt;/em&gt;&lt;br /&gt;
- check out the &lt;a href=&quot;http://online.wsj.com/article/SB119432112401983655.html&quot;&gt;article&lt;/a&gt; from the &lt;em&gt;Wall Street Journal&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;
&lt;strong&gt;Related Articles:&lt;br /&gt;
&lt;/strong&gt;FDA can&#039;t guarantee drug safety. &lt;a href=&quot;http://www.fiercepharma.com/story/fda-can-t-guarantee-drug-safety/2007-11-02?utm_medium=nl&amp;amp;utm_source=link&quot;&gt;Report&lt;/a&gt;&lt;br /&gt;
Overseas drugmaking goes unsupervised. &lt;a href=&quot;http://www.fiercepharma.com/story/overseas-drugmaking-goes-unsupervised/2007-10-31?utm_medium=nl&amp;amp;utm_source=link&quot;&gt;Report&lt;/a&gt;&lt;br /&gt;
Final FDA bill lacks new DTC oversight. &lt;a href=&quot;http://www.fiercepharma.com/story/final-fda-bill-lacks-new-dtc-oversight/2007-09-21&quot;&gt;Report&lt;/a&gt;&lt;br /&gt;
House overhauls, passes PDUFA. &lt;a href=&quot;http://www.fiercepharma.com/story/house-overhauls-passes-pdufa/2007-09-20&quot;&gt;Report&lt;/a&gt;&lt;br /&gt;
FDA offers safety reforms to skeptical lawmakers. &lt;a href=&quot;http://www.fiercebiotech.com/story/fda-offers-safety-reforms-to-skeptical-lawmakers/2007-01-31?utm_medium=nl&amp;amp;utm_source=internal&quot;&gt;Report&lt;/a&gt;
&lt;/p&gt;
&lt;p&gt;
&lt;strong&gt;Read more on: &lt;/strong&gt;&lt;a href=&quot;http://www.fiercepharma.com/tags/fda-news&quot;&gt;FDA news&lt;/a&gt;
&lt;/p&gt;
</description>
 <comments>http://www.fiercepharma.com/story/panel-give-fda-power-recall/2007-11-06#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/fda">FDA</category>
 <category domain="http://www.fiercepharma.com/tags/fda-news">FDA news</category>
 <category domain="http://www.fiercepharma.com/tags/fda-recalls">FDA recalls</category>
 <pubDate>Tue, 06 Nov 2007 06:59:58 -0500</pubDate>
 <dc:creator />
 <guid isPermaLink="false">8070 at http://www.fiercepharma.com</guid>
</item>
</channel>
</rss>
